Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Michalski

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancerYing Xiao, Lech Papiez, Rebecca Paulus, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2006
Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancerRobert Timmerman, James Galvin, Jeff Michalski, et al.
Practical Radiation Oncology|February 1, 2020
Adherence of US Insurance Payer Policies to the American Society of Radiation Oncology Stereotactic Radiosurgery Model PolicyComron Hassanzadeh, Michael Roach, Keith Rich, et al.
Advances in Radiation Oncology|July 1, 2021
Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumorsSai Duriseti, James Kavanaugh, Sreekrishna Goddu, et al.
JCO Precision Oncology|May 15, 2024
Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate CancerJonathan D Tward, Lauren Lenz, Alexander Gutin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2010
Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology GroupLynn Million, James Anderson, John Breneman, et al.
The Journal of Urology|August 27, 2017
Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer DatabaseBenjamin W Fischer-Valuck, Yuan James Rao, Soumon Rudra, et al.
Practical Radiation Oncology|June 18, 2022
Lutetium-177 Prostate-Specific Membrane Antigen Therapy: A Practical ReviewAngela Y Jia, Rojano Kashani, Nicholas G Zaorsky, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2016
Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical TrialsNan Li, Ruben Carmona, Igor Sirak, et al.
Cancer|October 10, 2013
Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastomaRaymond B Mailhot Vega, Jane Kim, Marc Bussière, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancerYing Xiao, Lech Papiez, Rebecca Paulus, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2006
Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancerRobert Timmerman, James Galvin, Jeff Michalski, et al.
Practical Radiation Oncology|February 1, 2020
Adherence of US Insurance Payer Policies to the American Society of Radiation Oncology Stereotactic Radiosurgery Model PolicyComron Hassanzadeh, Michael Roach, Keith Rich, et al.
Advances in Radiation Oncology|July 1, 2021
Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumorsSai Duriseti, James Kavanaugh, Sreekrishna Goddu, et al.
JCO Precision Oncology|May 15, 2024
Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate CancerJonathan D Tward, Lauren Lenz, Alexander Gutin, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2010
Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology GroupLynn Million, James Anderson, John Breneman, et al.
The Journal of Urology|August 27, 2017
Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer DatabaseBenjamin W Fischer-Valuck, Yuan James Rao, Soumon Rudra, et al.
Practical Radiation Oncology|June 18, 2022
Lutetium-177 Prostate-Specific Membrane Antigen Therapy: A Practical ReviewAngela Y Jia, Rojano Kashani, Nicholas G Zaorsky, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2016
Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical TrialsNan Li, Ruben Carmona, Igor Sirak, et al.
Cancer|October 10, 2013
Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastomaRaymond B Mailhot Vega, Jane Kim, Marc Bussière, et al.
Pageof 11